{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T10:21:32Z","timestamp":1711448492801},"reference-count":21,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.5387\/fms.2017-23","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T18:38:58Z","timestamp":1529347138000},"page":"82-88","source":"Crossref","is-referenced-by-count":6,"title":["Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case report"],"prefix":"10.5387","volume":"64","author":[{"given":"Eiji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ohta-Nishinouchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ohta-Nishinouchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ohta-Nishinouchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ohta-Nishinouchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Odajima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohta-Nishinouchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2. Singh JA, Saag KG, Bridges SL Jr., <i>et al.<\/i> 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol, <b>68<\/b>: 1-26, 2016.","DOI":"10.1002\/art.39480"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3. Anderson LA, Gadalla S, Morton LM, <i>et al.<\/i> Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer, <b>125<\/b>: 398-405, 2009.","DOI":"10.1002\/ijc.24287"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Kamel OW, van de Rijn M, Weiss LM, <i>et al.<\/i> Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med, <b>328<\/b>: 1317-1321, 1993.","DOI":"10.1056\/NEJM199305063281806"},{"key":"4","unstructured":"5. Hoshida Y, Xu JX, Fujita S, <i>et al.<\/i> Lymphoproliferative disorders in rheumatoid arthritis: Clinicopanalysis analysis of 76 cases in relation to methotrexate medication. J Rheumatol, <b>34<\/b>: 322-331, 2007."},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Tokuhira M, Watanabe R, Nemoto T, <i>et al.<\/i> Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma, <b>53<\/b>: 616-623, 2012.","DOI":"10.3109\/10428194.2011.625101"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Ichikawa A, Arakawa F, Kiyasu J, <i>et al.<\/i> Methotrexate\/iatrogeic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol, <b>91<\/b>: 20-28, 2013.","DOI":"10.1111\/ejh.12116"},{"key":"7","unstructured":"8. Gaulard P, Swerdlow SH, Harris NL, <i>et al.<\/i> Other iatrogenic immunodeficiency associated lymphoproliferative disorders. In: WHO Classification of Tumors of the Haematopoietics and Lymphoid Tissues.<i> <\/i>4<sup>th<\/sup> ed. International Agency for Research on Cancer, Lyon, 350-351, 2008."},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Miyazaki T, Fujimaki K, Shirasugi Y, <i>et al.<\/i> Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Haematol, <b>82<\/b>: 1106-1109, 2007.","DOI":"10.1002\/ajh.21003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"11. Salloum E, Cooper DL, Howe G, <i>et al.<\/i> Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic disease. J Clin Oncol, <b>14<\/b>: 1943-1949, 1996.","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"10","unstructured":"12. Hayakawa M, Morita T. A case of rheumatoid arthritis with malignant lymphoma taking methotrexate. (in Japanese, Abstract in English) Riumachi, <b>35<\/b>: 683-687, 1995."},{"key":"11","doi-asserted-by":"crossref","unstructured":"14. Furusawa N, Ikeno T, Urakawa M, <i>et al.<\/i> A case of ileal perforation caused by a malignant lymphoma associated with Epstein-Barr virus following methotrexate therapy for rheumatoid arthritis. (in Japanese, Abstract in English) Nihon Rinsyo Geka Gakkai Zasshi (Journal of Japan Surgical Association), <b>67<\/b>: 2625-2629, 2006.","DOI":"10.3919\/jjsa.67.2625"},{"key":"12","doi-asserted-by":"crossref","unstructured":"15. Moriyama H, Ohtake Y, Hashizume Y. A case of ileal perforation caused by a malignant lymphoma following methotrexate therapy for rheumatoid arthritis. (in Japanese, Abstract in English) Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), <b>72<\/b>: 1461-1464, 2011.","DOI":"10.3919\/jjsa.72.1461"},{"key":"13","unstructured":"16. Onoda T, Nakagawa H, Toda H, <i>et al.<\/i> A case of ileal perforation caused by a malignant lymphoma following methotrexate therapy for rheumatoid arthritis. (in Japanese) Geka, <b>78<\/b>: 555-559, 2016."},{"key":"14","unstructured":"17. Tokuhira M, Saito S, Okuyama A, <i>et al.<\/i> Ckinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma, Sep 7: 1-10, 2017 [Epub ahead of print]."},{"key":"15","doi-asserted-by":"crossref","unstructured":"19. Maeda A, Yamaguchi A, Isogai M, <i>et al.<\/i> A study of primary malignant lymphoma of the small intestine. (in Japanese, Abstract in English) Nihon Rinsho Geka Igakukai Zasshi (The Journal of the Japanese Practical Surgeon Society), <b>57<\/b>: 2910-2917, 1996.","DOI":"10.3919\/ringe1963.57.2910"},{"key":"16","doi-asserted-by":"crossref","unstructured":"20. Saito S, Kaneko Y, Yamaoka K, <i>et al.<\/i> Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology, <b>56<\/b>: 940-946, 2017.","DOI":"10.1093\/rheumatology\/kex002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"21. Inui Y, Matsuoka H, Yakushijin K, <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma, <b>56<\/b>: 3045-3051, 2015.","DOI":"10.3109\/10428194.2015.1022769"},{"key":"18","unstructured":"22. Takanashi S, Aisa Y, Ito C, <i>et al.<\/i> Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression. Rheumatol Int, Oct; <b>37<\/b>(10): 1629-1633, 2017 [Epub ahead of print]."},{"key":"19","unstructured":"23. Shimizu T, Tetsuka T, Ito K, <i>et al.<\/i> Two cases suspected of methotrexate-associated lymphoproliferative disorders of lung. (in Japanese, Abstract in English) Nihon Kokyuki Gakkai Zasshi (The Annals of the Japanese Respiratory Society), <b>3<\/b>: 245-250, 2014."},{"key":"20","doi-asserted-by":"crossref","unstructured":"24. Kameda H, Okuyama A, Tamaru J, <i>et al.<\/i> Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol, <b>26<\/b>: 1585-1589, 2007.","DOI":"10.1007\/s10067-006-0480-2"},{"key":"21","unstructured":"25. Tomiyama K, Sashikata T. A case of malignant lymphoma with diffuse pulmonary ground-glass opacity. (in Japanese, Abstract in English) Nihon Kokyuki Gakkai Zasshi (The Annals of the Japanese Respiratory Society), <b>2<\/b>: 73-77, 2013."}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/64\/2\/64_2017-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T12:23:44Z","timestamp":1571487824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/64\/2\/64_2017-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2017-23","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}